Journal
MOLECULAR MICROBIOLOGY
Volume 76, Issue 2, Pages 365-377Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1365-2958.2010.07099.x
Keywords
-
Categories
Funding
- NIH [AI43268, AI026170]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026170, R01AI043268, R37AI026170, R22AI026170, R21AI043268] Funding Source: NIH RePORTER
Ask authors/readers for more resources
P>The human tubercle bacillus Mycobacterium tuberculosis can synthesize NAD+ using the de novo biosynthesis pathway or the salvage pathway. The salvage pathway of the bovine tubercle bacillus Mycobacterium bovis was reported defective due to a mutation in the nicotinamidase PncA. This defect prevents nicotinic acid secretion, which is the basis for the niacin test that clinically distinguishes M. bovis from M. tuberculosis. Surprisingly, we found that the NAD+de novo biosynthesis pathway (nadABC) can be deleted from M. bovis, demonstrating a functioning salvage pathway. M. bovis Delta nadABC fails to grow in mice, whereas M. tuberculosis Delta nadABC grows normally in mice, suggesting that M. tuberculosis can acquire nicotinamide from its host. The introduction of M. tuberculosis pncA into M. bovis Delta nadABC is sufficient to fully restore growth in a mouse, proving that the functional salvage pathway enables nicotinamide acquisition by the tubercle bacilli. This study demonstrates that NAD+ starvation is a cidal event in the tubercle bacilli and confirms that enzymes common to the de novo and salvage pathways may be good drug targets.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available